Skip to main content
OpenTrials

Clinical trial condition

Hepatitis B, Chronic

Explore clinical trials studying Hepatitis B, Chronic. Study availability and eligibility vary by location and protocol.

162 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis B, Chronic trial results

Completed

Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1)

NCT05630807

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Davis, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Palo Alto, California, United States
View all 177 locations
View Trial Details
Completed

Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection

NCT04856085

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Investigative Site San Francisco, California, United States
  • Investigative Site Miami, Florida, United States
  • Investigative Site Orlando, Florida, United States
  • Investigative Site Baltimore, Maryland, United States
View all 37 locations
View Trial Details
Completed

A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy

NCT05276297

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Edegem, Belgium
  • GSK Investigational Site Sliven, Bulgaria
  • GSK Investigational Site Sofia, Bulgaria
  • GSK Investigational Site Sofia, Bulgaria
View all 51 locations
View Trial Details
Completed

A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B

NCT04225715

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Tokuda Hospital Sofia Sofia, Bulgaria
  • University Multiprofile Hospital For Active Treatment "Sveti Ivan Rilski" EAD Sofia, Bulgaria
  • University of Calgary Calgary, Alberta, Canada
  • Uni of Alberta Hospital Edmonton, Alberta, Canada
View all 33 locations
View Trial Details
Completed

A Study of JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 in Treatment-naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) Infection

NCT04439539

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Ruane Clinical Research Group Inc Los Angeles, California, United States
  • UPMC Center For Liver Diseases Pittsburgh, Pennsylvania, United States
  • Liver Institute Northwest Seattle, Washington, United States
  • University of Calgary Calgary, Alberta, Canada
View all 47 locations
View Trial Details
Completed

A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection

NCT05123599

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • UZ Antwerpen Edegem, Belgium
  • UZA-SGS Edegem, Belgium
  • Hopital Beaujon Clichy, France
  • Hopital de La Croix Rousse Lyon, France
View all 13 locations
View Trial Details
Completed

An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants

NCT05275023

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Toronto General Hospital Toronto, Ontario, Canada
  • Fakultni nemocnice Hradec Kralove Hradec Králové, Czechia
  • IKEM Prague, Czechia
  • Hopital Beaujon Clichy, France
View all 26 locations
View Trial Details

Related conditions